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Signal transductionThe B cell receptor (BCR) transduces antigen binding into alterations in the activity of intracellular signaling
pathways through its ability to recruit and activate the cytoplasmic protein-tyrosine kinase Syk. The
recruitment of Syk to the receptor, its activation and its subsequent interactions with downstream effectors
are all regulated by its phosphorylation on tyrosine. This review discusses our current understanding of how
this phosphorylation regulates the activity of Syk and its participation in signaling through the BCR.
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B cells are essential components of the adaptive immune response,
producing antigen-speciﬁc antibodies for the targeting of foreign
molecules and cells. Foreign particles are recognized by the B cell
receptor (BCR) for antigen, which comprises a membrane-bound
immunoglobulin that binds the antigen and an associated hetero-
dimer of disulﬁde-linked Ig-α (CD79a) and Ig-β (CD79b) subunits
that are required for transducing this binding into alterations in
intracellular signaling pathways [1,2]. Although none of the compo-
nents of the BCR complex has intrinsic enzymatic activity, their
engagement leads to the enhanced phosphorylation of multiple
intracellular proteins on tyrosine, which occurs through the recruit-
ment and activation of cytoplasmic protein-tyrosine kinases [1,3–6].
Spleen tyrosine kinase (Syk) is a critical component of this signaling
machinery. Studies in “knockout”mice and cell lines indicate that Syk
is essential for most of the biochemical responses to BCR engagement
[7–10].
Syk was originally identiﬁed at the protein level as a 40-kDa
proteolytic fragment containing the catalytic domain that was isolated
from bovine thymus based on its ability to phosphorylate a synthetic
peptide substrate [11]. A kinase of the same size was isolated from
porcine spleen [12]. Antibodies against this active fragment identiﬁed
the full-length enzyme as a 72-kDa protein, a size conﬁrmedwhen the
cDNA was sequenced [13,14]. Syk has at its amino terminus a tandem
pair of Src homology 2 (SH2) domains separated by a 60-amino acid
linker (linker A) (Fig. 1). A C-terminal catalytic domain is connected to
the tandem SH2 domains by a stretch of 106-amino acids (linker B)ll rights reserved.that contains multiple sites of phosphorylation [15,16]. A role for Syk
in cellular signaling was ﬁrst identiﬁed in B lymphocytes [17–19], but
Syk is expressed in many cell types including most cells of the
hematopoietic system, and at lower levels in some epithelial cells,
ﬁbroblasts, hepatocytes, vascular smooth muscle cells, endothelial
cells and neuronal cells [20,21]. A variant of Syk, SykB, which lacks a 23
amino acid “linker insert” from the linker B region due to alternative
splicing of exon 7, also is expressed in a variety of cell types [22–25].
The ζ-chain associated protein of 70 kDa (Zap-70) is a Syk homolog
expressed in T cells and NK cells and is the only other member of the
Syk-family of cytoplasmic protein-tyrosine kinases [26]. Zap-70, like
SykB, lacks a linker insert region.
2. Activation of Syk in B lymphocytes by binding to the antigen
receptor
2.1. Phosphorylation of tyrosines in the receptor ITAM
Signaling is initiated in B cells when BCR complexes become
aggregated. Rapidly following aggregation, the cytoplasmic tails of Ig-
α and Ig-β are phosphorylated on tyrosines located in a stretch of
amino acids known as an immunoreceptor tyrosine-based activation
motif (ITAM) [1,3,27–29]. ITAMs are found not only within these two
components of the BCR complex, but also within subunits of many
additional immune cell receptors – examples include the T-cell
antigen receptor (TCR), the immunoglobulin receptors FcɛRI, FcγRI,
and FcγRIIa, and the DAP12 component of NK cell activating receptors
and integrins – and in cytoplasmic proteins of the ERM family [30–36].
ITAMs have the consensus sequence (D/E)X2YX2LX7–10YX2(L/I). For
Ig-α, this sequence is ENLYEGLNLDDCSMYEDI. The phosphorylation of
the two tyrosines within the ITAM leads to the physical recruitment of
Fig. 1. Model of Syk showing approximate locations of major sites of tyrosine-
phosphorylation.
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its tandem pair of SH2 domains [37–39]. Interestingly, a number of
virally encoded proteins also contain ITAM sequences, which they use
to co-opt Syk for their own nefarious purposes [35,40,41].
The initial phosphorylation of the ITAM is catalyzed by a member
of the Src-family of cytoplasmic protein-tyrosine kinases. Several
members of this family are expressed in B cells, but, of these, Lyn is
thought to be particularly important and its elimination from mice
yields a pronounced B cell phenotype [42–48]. Lyn associates with the
clustered BCR [49–51] and catalyzes the phosphorylation of the ﬁrst
(N-terminal) tyrosine of the ITAM. This speciﬁcity can be demon-
strated through in vitro analyses of kinase-substrate interactions and
in a cellular model of BCR signaling reconstituted in insect cells
[52,53]. Structural studies indicate that this speciﬁcity for the ﬁrst
ITAM tyrosine is dictated by the glutamate at the P-3 position and the
glycine at the P+2 position [52]. The glutamate provides side chain
hydrogen bonding interactions with residues in the catalytic cleft of
Lyn while the glycine allows for the conformational ﬂexibility needed
for favorable binding of this region of the ITAM to the kinase.
Accordingly, the stoichiometry of phosphorylation of the ﬁrst tyrosine
of Ig-α in activated B cells is much greater than that of the second [54].
Optimal signaling, however, requires the phosphorylation of both
tyrosines of the ITAM as two phosphotyrosines are needed for a high
afﬁnity interactionwith Syk's tandem pair of SH2 domains. The kinase
that phosphorylates the second tyrosine of the ITAM is less certain,
but a prime candidate is Syk, itself. Syk is capable of phosphorylating
Ig-α in vitro and, in the reconstituted insect cell model system, its
expression leads to the phosphorylation of both ITAM tyrosines even
in the absence of Lyn [53]. Consistent with this observation, BCR-
mediated signaling and the recruitment of Syk to the receptor can and
does occur, albeit at a slower initial rate, in B cells that lack Lyn
[7,44,55–57].
2.2. Activation of Syk by binding to phosphorylated ITAMs
Syk binds with high afﬁnity to the doubly phosphorylated ITAM
through its tandem pair of SH2 domains. These two domains are
juxtaposed to form a Y-shaped structure that is held together and
oriented properly through domain-domain interactions and through
linker A for the simultaneous engagement of both ITAM phospho-
tyrosines. Linker A contains 3 α-helices, two of which form a
coiled-coil [58]. Each SH2 domain recognizes one of the two
pYXXL/I sequences within the phosphorylated ITAM via two major
binding pockets, one that accommodates the phosphotyrosine and
another that binds the hydrophobic side chain of the P+3 residue.
Overall binding occurs in a head-to-tail orientation with the N-
terminal SH2 domain of Syk interacting with the second phospho-tyrosine of the ITAM and the C-terminal domain binding the ﬁrst.
The interaction surface between the two SH2 domains is sufﬁciently
small and linker A sufﬁciently ﬂexible to allow the tandem SH2
domains to exist in either an open or a closed conformation
[58–61]. This facilitates Syk's interactions with ITAMs that vary in
the degree of spacing between the two pYXXL/I binding motifs.
Thus, Syk can bind with high afﬁnity to immunoreceptors that have
as few as 10 or as many as 15 residues separating the two ITAM
phosphotyrosines [60].
Each of the SH2 domains contains all of the amino acid residues
required to bind independently to one of the pYXXL/I sequences of
the ITAM [58]. Thus, it has been suggested that Syk can interact also
with proteins containing only one phosphotyrosine. The C-terminal
SH2 domain, when expressed independently of the N-terminal
domain and linker A, does, in fact, retain the ability to recognize and
bind phosphopeptides on its own [62]. It is reasonable to speculate
that the C-terminal SH2 domain mediates the initial recruitment of
Syk to the BCR after phosphorylation of the ﬁrst ITAM tyrosine by Lyn.
Inactivation of the C-terminal SH2 domain does block the ability of Syk
to signal when expressed in Syk-deﬁcient DT40 B cells [37].
Subsequent phosphorylation of the second ITAM tyrosine by Syk
would then allow for a much higher afﬁnity interaction in which both
SH2 domains are engaged. Interestingly, Syk also is recruited to and
activated by engagement of a class of receptors exempliﬁed by Dectin-
1 and C-type lectin-like receptor 2 (CLEC-2) [36] that contain only a
single pYXXL motif, suggesting an interaction mediated by a single
SH2 domain. However, the mechanism by which Syk binds to these
receptors is not completely understood as mutagenesis studies
indicate that both SH2 domains are still required [63].
The binding of Syk to the phosphorylated ITAMs of clustered BCR
complexes leads to its activation. In vitro studies indicate that the
simple binding to Syk in solution of a dually phosphorylated peptide
with the sequence of an ITAM is sufﬁcient to fully activate the kinase
[64–66]. In the X-ray crystal structure of the Syk homolog, Zap-70, the
linker A region makes close contacts with the C-terminal lobe of the
kinase domain and with residues in linker B forming what is referred
to as a “linker-kinase sandwich” [67]. These interactions likely restrict
the ﬂexibility of the hinge region of the kinase domain preventing it
from transitioning from an inactive to an active conformation.
Engagement of the tandem SH2 domains by a dually phosphorylated
ITAM reorients the domains and alters the conformation of linker A to
disrupt these interactions. An analysis of Syk's structure by electron
microscopy suggests an autoinhibited conformation comparable to
that of Zap-70 indicating that Syk is likely to be regulated and
activated in an analogous fashion [68]. Consequently, the binding of
Syk to its reaction product, a dually phosphorylated ITAM, activates
the enzyme and generates a positive feedback loop to promote the
phosphorylation of additional ITAM tyrosines to recruit evenmore Syk
molecules to the clustered BCR complexes [53,66].
Syk, recruited to the BCR, can catalyze the phosphorylation of ITAM
tyrosines and at least one non-ITAM tyrosine (Y204) on Ig-α [69].
These residues lie within predicted AP-2 binding sites and the
conversion of all three to non-hydrophobic residues severely impairs
receptor internalization [69]. If the activity of Syk is then inhibited, the
Syk-receptor complex rapidly dissociates and the receptor is inter-
nalized most likely due to its rapid dephosphorylation by protein-
tyrosine phosphatases [70]. Thus, phosphorylated receptors that bind
and activate Syk are retained at the cell surface while clustered, but
nonphosphorylated receptors are internalized. The persistence of Syk-
BCR complexes at the plasmamembrane likely plays an important role
in determining the length of time that Syk remains active following
the initial engagement of the receptor. The prolonged activation of Syk
is required for some receptor-stimulated events such as the activation
of the NFAT transcription factor, which requires Syk to remain active
for more than one hour following receptor ligation [70]. As wewill see
below, the binding of Syk to the adaptor protein BLNK/SLP-65 at the
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3. The phosphorylation of Syk on tyrosine
Shortly following BCR engagement, Syk that has been recruited to
the receptor becomes phosphorylated on multiple tyrosines through
both autophosphorylation and phosphorylation by Lyn [15–18]. In
solution in the presence of ATP, Syk readily catalyzes an autopho-
sphorylation reaction, the rate of which is enhanced if Lyn is present
[66]. Thus, the recruitment of Syk to a receptor complex where Lyn is
resident and active provides an additional mechanism to increase the
rate at which it becomes phosphorylated and activated. Interestingly,
like ITAM-binding, phosphorylation alone is sufﬁcient to fully activate
the kinase [66]. The ability of either ITAM-binding or phosphorylation
to activate Syk allows the kinase to be active within cells both when
phosphorylated, but released from the receptor, and when not
phosphorylated, but bound to the receptor. Active kinase that has
dissociated from the receptor can be found in the non-membrane
fraction of cells [72]. In fact, active, tyrosine-phosphorylated Syk and
Zap-70 have even been observed in the nucleus of activated B and T
cells, respectively [73,74]. While a role for these kinases in the nucleus
of immune cells is not known, Syk has been reported to function as a
transcriptional repressor in breast cancer cells by binding to SP-1 and
recruiting histone deacetylases to a subset of SP-1-regulated promo-
ters [75]. However, the phosphorylation of Syk is much more
complicated than simple activation as it occurs on multiple tyrosines,
some of which modify the activity of the kinase directly through
conformational changes and many of which serve dual roles as
docking sites for proteins that contain SH2 or related phosphotyr-
osine-recognition domains.
3.1. Phosphorylation of tyrosine-130
Of the sites of tyrosine-phosphorylation on Syk that have been
characterized, the one closest to the N-terminus is Y130 (numbered
according to its position in the murine enzyme; this is Y131 in human
Syk). This tyrosine is located in one of the three α-helices of linker A
and is a prominent site of autophosphorylation in vitro [5]. It would be
expected that this site is exposed to solution and available for
phosphorylation based on the X-ray crystal structure of Zap-70, which
has an equivalent tyrosine that also is a site of autophosphorylation
[67,76]. The phosphorylation of Y130 can be detected at a low level on
Syk isolated from cells following receptor crosslinking or at a higher
level on Syk isolated from cells in which protein-tyrosine phospha-
tases have been inhibited [16,77]. The phosphorylation of Y130 or its
replacement with glutamate to mimic phosphorylation has interest-
ing effects on the activity of Syk as it both disrupts its interactions with
the phosphorylated ITAMs of the BCR complex and enhances its
catalytic activity [78]. The presence of an acidic amino acid at position
130 partially uncouples contacts between the two SH2 domains by
disordering the structure of linker A [77]. The resultingmore extended
conformation of the tandem SH2 domains lacks the proper orientation
for a high afﬁnity, two-site interaction with a dually phosphorylated
ITAM and instead exhibits a reduced binding afﬁnity similar to that of
a single SH2 domain. The disordering of linker A caused by the
phosphorylation of Y130 likely also accounts for the elevated kinase
activity as this would be expected to destabilize the interactions of
linker A with linker B and the catalytic domain. Thus, the
phosphorylation of Y130 and consequent decrease in afﬁnity for
ITAMs results in the release of a bound, but active, kinase from the
receptor and decreases the ability of a phosphorylated, active kinase to
bind to the receptor [78]. A physiological role for Y130-phosphoryla-
tion is not known, but it could contribute to the activation of Syk in
response to oxidative stress since it is readily observed in cells treated
with hydrogen peroxide [77,78]. The expression of a mutant form ofSyk with Y130 replaced by glutamate enhances the ability of the
kinase to bind to and phosphorylate centrosomal components in
breast cancer cells and activates integrins through “inside-out”
signaling in B cells [79,80]. Thus, this mutant can be a useful tool for
identifying roles for active Syk in the absence of its associationwith an
ITAM-bearing receptor.
3.2. Phosphorylation of tyrosine-290
The phosphorylation of Y290 (Y296 in human Syk) occurs in vitro
during an autophosphorylation reaction [15] and has been reported
also in a mass spectrometric analysis of proteins that are phosphory-
lated on tyrosine in lung cancer cells [81]. It does not appear to be a
major site of phosphorylation and its modiﬁcation has not yet been
reported in intact B cells activated through the BCR. Y290 lies in the
linker insert region of Syk, the section near the N-terminus of linker B
that is missing from SykB or Zap-70. This linker insert is interesting in
that it has been reported to affect the subcellular localization of Syk in
breast epithelial cells by serving as a nuclear localization signal [82].
However, in B cells, a SykB-enhanced green ﬂuorescent protein (EGFP)
fusion protein or a Syk-EGFP fusion protein lacking the N-terminal 2/3
of linker B is still able to enter the nucleus due to the presence of a
separate shuttling sequence located at the C-terminal end of linker B
[73]. A role for the phosphorylation of Y290 has not been identiﬁed as
the replacement of this residue with phenylalanine has no noticeable
effect on the ability of Syk to signal through either FcɛRI or the TCR
[26]. Thus, it is unlikely that it is the phosphorylation of Y290 that
underlies the intrinsic differences in the activities of Syk and SykB.
Compared to Syk, SykB exhibits a reduced ability to bind to and
mediate signaling from ITAM-bearing receptors [26].
3.3. Phosphorylation of tyrosine-317
Y317 (Y323 in human Syk) is in the linker B region and is a major
site of autophosphorylation and of phosphorylation in intact B cells
following engagement of the antigen receptor [15,16]. It has also been
identiﬁed in mass spectrometric analyses of phosphoproteins in B
cells and mast cells [83,84]. The analogous residue in Zap-70, Y292, is
present in a ﬂexible, disordered region of linker B not visible in the X-
ray crystal structure [67]. Thus, Y317 is probably exposed, which is
consistent with the rapid rate at which it is autophosphorylated in
vitro [78]. However, a catalytically inactive Syk is phosphorylated on
Y317 in cells that express Lyn and the phosphorylation of Y317 is
reduced substantially in DT40 B cells that lack Lyn [16,85]. Thus, Src-
family kinases are major contributors to the phosphorylation of this
site in cells. The effects of phosphorylation at Y317 are interesting as
they inhibit the ability of the kinase to signal from the BCR in B cells or
from FcɛRI in mast cells [16,85–88]. Thus, the substitution of Y317
with phenylalanine yields an enzyme with a greatly enhanced
capacity to couple the BCR to the increased phosphorylation of several
downstream targets including phospholipase C-γ2 (PLC-γ2) and the B
cell linker protein/SH2 domain-containing leukocyte protein of
65 kDa (BLNK/SLP-65) (also known as BASH) [85]. As a consequence,
the production of inositol 3,4,5-trisphosphate (IP3) is enhanced,
which increases the amplitude and duration of calcium mobilization.
A similar increase in the receptor-stimulated production of IP3 is
observed in B cells that lack Lyn where the phosphorylation of Y317 is
reduced as a consequence [85]. The replacement of Y292 of Zap-70
with phenylalanine also creates a gain-of-function mutant that
enhances signaling from the TCR [89].
The phosphorylation of Syk on Y317 enhances its interactions
with Casitas B-lineage lymphoma (Cbl)-family proteins. c-Cbl is the
cellular homolog of v-Cbl, the product of the oncogene of the Cas
NS-1 retrovirus, which causes pre- and pro-B cell lymphomas in
infected mice [90]. As ﬁrst described in mast cells, c-Cbl is an
inhibitor of Syk-dependent signaling [91]. Several proximal BCR-
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Ig-α, PLC-γ and Vav-1 and the mobilization of calcium are elevated
in B cells from mice lacking both c-Cbl and its homolog Cbl-b [92].
Both yeast two-hybrid analyses and pull-down assays indicate that
the interaction of c-Cbl with Syk is enhanced by its phosphorylation
on Y317 [86,93,94]. Furthermore, the overexpression of c-Cbl
inhibits Syk-dependent signaling in B cells and the activity of Syk
ectopically expressed in COS-7 cells in a manner dependent on the
presence of Y317 [86,94].
The binding of c-Cbl and Cbl-b to pY317 of Syk is mediated by
their N-terminal tyrosine kinase binding (TKB) domains. The TKB
domain is constructed from three subdomains: a four-helix bundle,
a calcium-binding EF hand and a variant SH2 domain. A consensus
target sequence for the TKB domain has been identiﬁed as (N/D)
XpY(S/T)XXP based on analyses of libraries of phosphopeptide
ligands and the sequences of the binding regions of Cbl-interacting
proteins [90,95,96]. The amino acid sequences surrounding pY317 in
murine and human Syk are NPpYEPTG and NPpYEPEL, respectively.
Phosphopeptides of this type are bound by the TKB domain in an
overall orientation similar to that of a phosphopeptide bound to a
conventional SH2 domain [97]. The asparagine (N) at position pY-2
makes major hydrogen bonding contacts not only with residues in
the TKB domain, but also with one of the oxygens on the phosphate
group of the phosphotyrosine [97]. This intrapeptidyl hydrogen
bond is essential for binding. While it is not known if this
intramolecular bond forms prior to or following the binding of the
peptide to the TKB domain, it is interesting to note that the
phosphorylation of Y317 results in a reduced electrophoretic
mobility of Syk or of the isolated linker B region of Syk on an
SDS-polyacrylamide gel suggesting that phosphorylation results is a
local conformational change [16,98].
In addition to the TKB domain, Cbl-family proteins contain a Zn-
binding RING ﬁnger domain and a C-terminal region containing
multiple proline-rich sequences and several sites of tyrosine-phos-
phorylation that govern their interactions with a wide array of
proteins that possess either SH3 or SH2 domains [90,96]. In general,
TKB domains bind their targets with relatively low afﬁnity – the Kd for
the binding of a Syk-derived phosphopeptide to the c-Cbl domain is
approximately 1.5 μM – and the C-terminal regions of the Cbl-proteins
make major contributions to their interactions with activated tyrosine
kinases [99,100]. In fact, interactions between Syk and c-Cbl have been
described that are independent of pY317 and/or the TKB domain
[86,91,93,101].
The RING ﬁnger domains recruit E2 ubiquitin conjugating enzymes
and confer on Cbl-family proteins E3 ubiquitin ligase activity [102].
Consequently, the interaction of Cbl-family proteins with activated
Syk leads to its ubiquitination [103,104]. The attachment of poly-
ubiquitin chains to proteins by E3 ligases is well known to target
proteins for degradation through the 26 S proteosome; and, indeed,
Cbl and/or ubiquitination-dependent decreases in the concentration
of Syk have been described that can be reversed by the application to
cells of proteosome inhibitors [79,103–107]. However, mono- and
polyubiquitination can have many effects on proteins separate from
proteosomal degradation. These include changes in enzymatic
activity, the promotion or inhibition of protein–protein associations
and alterations in protein trafﬁcking [108]. For example, c-Cbl
catalyzes the extensive monoubiquitination of the receptors for
epidermal growth factor and platelet-derived growth factor leading
to their internalization and trafﬁcking to the lysosome [109,110]. Syk is
extensively ubiquitinated following its activation via the engagement
of the BCR in primary B cells or the collagen receptor GPVI in platelets
[92,111]. This ubiquitination is abrogated in B cells lacking both c-Cbl
and Cbl-b and in platelets lacking c-Cbl resulting in enhanced
receptor-mediated activation of Syk and downstream signaling.
However, in both cell types, Cbl-dependent ubiquitination occurs in
the absence of any observable decrease in the level of Syk indicating arole for ubiquitination that is independent of protein degradation. In
c-Cbl-deﬁcient platelets, the phosphorylation of Syk following platelet
aggregation is prolonged, suggesting that either Syk's ubiquitination
or its association with c-Cbl promotes its interactions with protein-
tyrosine phosphatases that would normally dephosphorylate and
inactivate the kinase [111].
The recruitment of proteins to phosphorylated Y317 on Syk is not
restricted to Cbl-family proteins. In our hands, the most commonly
encountered binding partner for Syk in a yeast two-hybrid screen is
p85, the regulatory subunit of phosphoinositide-3-kinase (PI3K) [98].
p85 has two SH2 domains that mediate its interactions with
phosphorylated kinases or adaptor proteins to both redirect the lipid
kinase within the cell – typically to the plasma membrane – and
relieve inhibition of the constitutively associated 110 kDa catalytic
subunit. The more C-terminal of the two SH2 domains of p85 interacts
directly with Syk when it is phosphorylated on Y317 [98]. Despite the
lack of similarity between the sequence of amino acids that surrounds
Y317 and that of a classical ligand for a p85 SH2 domain (pYXXM),
molecular modeling supports a reasonable ﬁt between pY317 and the
SH2 domain. In fact, this interaction is more robust than the
interaction of Syk with the c-Cbl TKB domain [98]. Thus, the
phosphorylation of Syk on Y317 by Syk itself or by Src-family kinases
leads to the formation of a complex between Syk and PI3K.
While the activation of PI3K through the BCR in B cells is
dependent on Syk [112], it is not clear whether or not the
phosphorylation of Y317 plays an important role as p85 is well
known to interact with other phosphorylated adaptor proteins such as
BCAP, CD19, or Gab1 [113–115]. However, it is becoming increasingly
clear that this interaction does play a positive role in a subset of Syk's
functions. For example, both Syk and PI3K are required for
phagocytosis mediated by IgG-receptors that bear cytoplasmic
ITAMs [116–120]. In COS cells transfected to express FcγRIIA, the
phagocytosis of IgG-coated red blood cells requires the ectopic
expression of catalytically active Syk, but is not supported by the
expression of a Syk mutant lacking Y317 [98]. This Syk(Y317F) mutant
also fails to support FcγRIIA-mediated activation of the kinase Akt,
which is a downstream target of PI3K. Furthermore, the phagocytosis
of opsonized particles through FcγR's promotes a direct association
between Syk and PI3K [121]. In differentiated, polarized HL-60 cells,
Syk localizes to the lamellipodum at the leading edge of cells
migrating on ﬁbronectin and recruits PI3K p110δ to this location in
an interaction dependent on Y317, suggesting an important role for a
Syk-PI3K interaction in integrin-mediated leukocyte motility [122].
Also, the HIV Nef protein activates a Src-family kinase in the Golgi that
phosphorylates Zap-70 on Y292 in T cells or Syk on Y317 in
promonocytic cells to promote the binding and activation of PI3K
leading to the down-regulation of cell surfaceMHC-1 [123]. In atypical
myelodisplastic syndrome, a gene rearrangement generates a TEL-Syk
fusion protein that is oligomerized, phosphorylated on tyrosine and
bound to p85, leading to the constitutive activation of PI3K and Akt
[124]. Syk-PI3K complexes also are important for the inﬂammatory
response of neutrophils to monosodium urate crystals [125] and the
internalization of human rhinovirus via ICAM-1 in epithelial cells
[126].
Thus, both Cbl-family proteins and p85 have the capacity to bind to
Syk when it is phosphorylated on Y317. In fact, competition between
the two proteins for binding has been hypothesized to determine the
pathway by which IgG-receptors internalize immune complexes of
different sizes [121]. The phagocytosis of large, IgG-coated particles
through FcγR's requires PI3K activity and promotes a direct associa-
tion between Syk and p85. In contrast, the endocytosis of small
immune complexes does not require active PI3K and is accompanied
by a decrease in the Syk-p85 interaction. This leads to the interesting
hypothesis that phagocytosis proceeds with an interaction of PI3K
with pY317 while endocytosis occurs in concert with an interaction of
c-Cbl with pY317 [121].
1119R.L. Geahlen / Biochimica et Biophysica Acta 1793 (2009) 1115–11273.4. Phosphorylation of tyrosines-342 and 346
Tyrosines 342 and 346 (348 and 352 in the human enzyme) lie
within linker B and are major sites modiﬁed both through autopho-
sphorylation in vitro and by phosphorylation in intact B cells following
the crosslinking of the BCR [15,16]. In conjunction with Y317, these
three tyrosines account for the bulk of the phosphorylation that
occurs in the interdomain B region of Syk. Since Y342 and Y346 are
present on the same tryptic peptide, it can be shown by peptide
mapping or mass spectrometry that a single molecule of Syk can
become phosphorylated on both sites [15,16,81,83,84,127]. BCR
engagement leads to a mixture of forms of phosphorylated Syk,
some modiﬁed within this region on only one of these two tyrosines
and others phosphorylated on both. Studies in RBL-2H3 mast cells
activated through FcɛRI indicate that, of these two sites, Y342 is the
predominant site of phosphorylation as determined through the use
of phosphopeptide-speciﬁc antibodies [128]. Little or no phosphor-
ylation of Syk on Y346 is observed in this system. However, several
mass spectrometric analyses of phosphopeptides derived from a
variety of cell types have identiﬁed both the dually phosphorylated
tryptic peptide as well as a singly phosphorylated peptide, but the one
modiﬁed on Y346 [81,83,84,127]. Also, Y346 is the predominant site of
autophosphorylation in vitro [15]. Thus, more work needs to be done
to establish ﬁrmly the conditions underwhich one or the other or both
tyrosines become phosphorylated. Both sites on Syk can be phos-
phorylated following BCR crosslinking in DT40 B cells that lack Lyn;
and the rate of autophosphorylation at these sites in vitro is enhanced
by ITAM-binding [16,66]. However, both also can be phosphorylated
on a catalytically inactive mutant of Syk expressed in cells where Lyn
is present [16]. Thus, both autophosphorylation and phosphorylation
in trans by a Src-family kinase can contribute to the modiﬁcation of
Y342 and Y346.
Unlike the phosphorylation of Y317, the modiﬁcation of Y342
and Y346 plays a positive role in Syk-dependent signaling.
Consequently, their elimination or replacement by phenylalanines
reduces signaling downstream of ITAM-bearing receptors. In gen-
eral, the elimination of both Y342 and Y346 has more profound
effects on kinase function than the elimination of either single site.
When expressed in B cells or mast cells, Syk mutants lacking both
tyrosines exhibit a reduced ability to couple the BCR or FcɛRI to the
phosphorylation of PLC-γ and the mobilization of calcium
[85,88,128,129]. In mast cells or RBL-2H3 cells expressing the
double mutant, there is a decrease in the receptor-induced
phosphorylation of LAT and SLP-76 [88,128] and in mast cells from
Syk-deﬁcient mice, a decrease in the FcɛRI-stimulated phosphoryla-
tion of Vav-1 [88]. The elimination of each individual tyrosine has
both redundant and unique effects. The replacement of Y342 with
phenylalanine results in a more substantial decrease in the receptor-
stimulated phosphorylation of PLC-γ in B cells and mast cells and of
LAT, SLP-76 and Vav-1 in mast cells than does the replacement of
Y346 [88,128,129]. In contrast, the elimination of Y346 more
strongly decreases the FcɛRI-stimulated phosphorylation of ERK
and Akt in primary mast cells than does the elimination of Y342
[88]. Zap-70 has an analogous pair of tyrosines at positions 315 and
319 that also are important for its activity. Zap-70 lacking Y315 is
unable to restore BCR-stimulated signaling to Syk-deﬁcient DT40 B
cells and Zap-70 lacking Y319 is unable to mediate TCR-dependent
signaling in Jurkat T cells [130–132]. Elimination of either Y315 or
Y319 impairs both positive and negative selection of T cells in mice
[133,134].
Many of the signaling defects exhibited by Syk mutants in which
Y342 and Y346 have been replaced with phenylalanines can be
reversed by the simultaneous elimination of the inhibitory tyrosine at
Y317. Consequently forms of Syk with all three tyrosines (Y317, Y342
and Y346) replaced by phenylalanines can reconstitute much of BCR-
or FcɛRI-mediated signalingwhen expressed in Syk-deﬁcient B cells ormast cells, respectively [85,88]. In turn, Zap-70 can reconstitute many
aspects of TCR-stimulated signaling in T cells even if the entire linker B
region is eliminated [135]. However, even in the absence of Y317,
maximal signaling by Syk in B cells still requires Y342 and Y346 [85].
This dependence is especially apparent when low doses of activating
anti-IgM antibody are used to crosslink the BCR or if alternative
pathways such as those mediated through PI3K are inhibited. Under
these conditions, the phosphorylation of Y342 and Y346 are needed
for a robust receptor-mediated phosphorylation of PLC-γ2, generation
of IP3 and mobilization of calcium.
The phosphorylation of Y342 and Y346 enhances signaling both by
increasing the activity of Syk and by generating docking sites that
mediate protein–protein interactions. Several proteins, including PLC-
γ, Vav-1 and Vav-2, the Src-family kinases Lck and Fgr, the p85 subunit
of PI3K and Grb2, have SH2 domains that can that bind to one or both
of these phosphotyrosines. Interestingly, these residues act individu-
ally and in concert to determine the identity of the protein that binds,
with some proteins binding when only one or the other tyrosine is
phosphorylated and others binding preferentially when both are
modiﬁed. The interaction between Syk and PLC-γ1 or 2 is mediated by
the C-terminal SH2 domain of the phospholipase [136–138] and is
blocked when both Y342 and Y346 are substituted with phenylala-
nines as ﬁrst shown for an interaction between PLC-γ1 and a CD8-Syk
fusion protein [138]. In vitro phosphopeptide-binding assays indicate
that the PLC-γ SH2 domain actually binds when both Y342 and Y346
are phosphorylated and binds poorly when only a single site is
modiﬁed [129].
Guanine nucleotide-exchange factors of the Vav-family interact
with Syk in a variety of cell types [139–142]. Binding of the Vav-1 SH2
domain is nearly completely disrupted by the replacement of Y342
with phenylalanine [139]. Consequently, the replacement of Y342
inhibits the recruitment of Vav-1 to Syk localized to lamellipodia of
migrating, differentiated HL-60 cells and inhibits the phosphorylation
of Vav-1 in mast cells [88,142]. The substitution of Y346 also decreases
the binding of Vav-1, but to a lesser extent (60%), and the replacement
of both tyrosines essentially eliminates the interaction [139].
Phosphopeptide-binding assays indicate that Vav-1 can interact
with a peptide containing only pY342, fails to bind one containing
only pY346, but interacts most strongly with a peptide containing
both phosphotyrosines [129].
Lck, which binds to Zap-70 in T cells [131,143], and Fgr, which binds
Syk in monocytes to inhibit β2 integrin-mediated cell spreading [144],
exhibit a similar preference for peptide ligands containing phospho-
tyrosines at both Y342 and Y346 [129]. In contrast, Grb2 binds
preferentially to a Syk-derived phosphopeptide modiﬁed only on
Y346, which may help explain why the deletion of this tyrosine
negatively affects the coupling of FcɛRI to the activation of ERK inmast
cells [88,129]. Thus, the nature of the proteins capable of binding to
Syk is dependent on the site of phosphorylation as well as the
stoichiometry of phosphorylation within the linker B region.
A structural analysis of the C-terminal SH2 domain of PLC-γ1
bound to a dually phosphorylated peptide derived from Syk linker B
explains themolecular basis for the unusual interaction of a single SH2
domain with a site containing two phosphotyrosines [129]. The SH2
domain binds pY342 in the canonical phosphotyrosine-binding
pocket that is common to all SH2 domains. However, it then
undergoes a substantial conformational change to accommodate the
pY346 residue within a second phosphotyrosine-binding pocket. Two
lysine residues from the SH2 domain, K54 and K56, interact with
pY346 within this second pocket, which actually buries more of the
phosphotyrosine residue than is buried in the primary pocket (Fig. 2).
The formation of this second phosphotyrosine-binding site increases
the afﬁnity of the SH2 domain for the phosphopeptide over sevenfold.
Of these two lysines, K56 is conserved in the sequences of all of the
SH2 domains known to be capable of binding this region of Syk when
it contains two phosphotyrosines, suggesting that it is particularly
Fig. 2. A stick representation (magenta) of the Syk linker B peptide showing the two
phosphoryl groups by ball-and-sticks (blue). The pY342 residue is on the right and
pY346 on the left. The SH2 domain is shown using a solvent accessible surface
representation where the contact region within 5 Å of the peptide is colored tan.
Table 1
SH2 domains that have been tested for their ability to bind to a dually phosphorylated
peptide containing both pY342 and pY346.
SH2 domain Sequence Binding
Grb2 NDVQHFKVLRDGAG No
Abl GRVYHYRINTASDG No
Fgr DHVKHYKIRKLDMG Yes
Lck EVVKHYKIRNLDNG Yes
SHP1 N DQVTHIRIQNSGDF No
SHP1C LRVTHIKVMCEGGR No
p85 N GNNKLIKIFHRD-G Yes
Vav1 VEVKHIKIMTAE-G Yes
Vav3 NEAKHIKILTRD-G Yes
PLC-γN GKVQHCRIHSRQDA No
PLC-γC GKIKHCRVQQE--G Yes
The position of K65 is underlined.
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Consistent with this idea, substitution of K56 with a glutamine results
in a sevenfold reduction in the afﬁnity of the PLC-γ1 SH2 domain for
the dually phosphorylated peptide. An analogous lysine is absent from
the SH2 domains of Grb2 and of a number of other domains that do
not interact strongly with a phosphopeptide containing both pY342
and pY346 [129].
The phosphorylation of Y342 and Y346 also enhances the
catalytic activity of Syk and likely accounts for much of the ability
of Lyn to activate the enzyme. The phosphorylation of the
analogous tyrosines on Zap-70 is catalyzed by Lck and is an
important step in the activation of Zap-70 following engagement of
the TCR [67,145]. The ability of Lck to phosphorylate and activate
Zap-70 is abrogated by the replacement of Y315 and Y319 with
phenylalanine [145]. In contrast, direct phosphorylation by Lck is
not needed for the activation of a Zap-70 mutant in which both
tyrosines are replaced by alanines. In the X-ray crystal structure of
Zap-70, both Y315 and Y319 have been replaced by phenylalanines,
which participate in aromatic–aromatic interactions with residues
in both linker A and the catalytic domain [67]. Unlike phenylala-
nines or perhaps tyrosines, neither alanines nor phosphotyrosines
would be able to stabilize the linker-kinase sandwich that
preserves the autoinhibited form of the kinase. Thus, phosphoryla-
tion on these residues would lead to the activation of the kinase. A
similar mechanism is suggested for Syk since the replacement of
Y342 and Y346 with phenylalanines reduces its ability to
phosphorylate LAB/NTAL when it is co-expressed with the kinase
in HEK 293T cells [145].
3.5. Phosphorylation of tyrosines-519 and 520
Tyrosines 519 and 520 (Y525 and 526 in the human enzyme)
are located in the activation loop within the catalytic domain. Both
residues are phosphorylated in an in vitro autophosphorylation
reaction and in B cells following engagement of the BCR [15,16].
Syk also is phosphorylated on both activation loop tyrosines
following clustering of FcɛRI in mast cells [146,147]. We were
unable to detect the phosphorylation of either Y519 or Y520 of acatalytically inactive mutant of Syk in B cells expressing Lyn
suggesting that Syk itself is the major catalyst of activation loop
phosphorylation [16]. However, in mast cells some Lyn-dependent
phosphorylation of the activation loop has been observed and is
thought to be important for the initial activation of Syk; and then
the bulk of the phosphorylation is catalyzed by Syk itself [147].
The activation loops of many protein kinases contain residues
whose phosphorylation leads to the upregulation of kinase activity
most often through alterations in substrate binding and/or enhance-
ment of the rate of phosphoryl transfer [148]. Thus, for many kinases,
catalytic activity is profoundly affected by the status of phosphoryla-
tion of the activation loop. For Syk, however, the situation is less clear.
Mutations in one or both of these tyrosines have little or no effect on
the catalytic activity of the enzyme when measured in an in vitro
kinase assay [37,149–151]. For example, the kinetics of substrate
phosphorylation catalyzed by the kinase domain of unphosphorylated
Syk are indistinguishable from those of either Syk pre-phosphorylated
on the activation loop tyrosines or Syk that has both tyrosines
replaced by phenylalanine [151]. These observations are consistent
with the orientation of the activation loop in the X-ray crystal
structure of the catalytic domain of Syk [152]. In this structure, the
activation loop adopts the same “loop-out” conformation that is
typically observed in active protein-tyrosine kinases with phosphory-
lated activation loops. Similarly, the activation loop of the isolated
catalytic domain of Zap-70 is in the activated conformation [153].
Thus, the unphosphorylated activation loop of Syk does not appear to
restrict access to the ATP or substrate binding pockets and does not
disturb the proper orientation of important catalytic residues within
the active site.
Despite the apparent lack of involvement of Y519 and Y520 in
regulating the catalytic activity of Syk, mutant forms of the kinase in
which these residues have been replaced with phenylalanines still
exhibit major signaling deﬁcits in cells [37,149,150,154]. In Syk-
deﬁcient DT40 B cells reconstituted with a form of Syk lacking both
activation loop tyrosines, the BCR-stimulated phosphorylation of
cellular proteins is reduced and the phosphorylation of PLC-γ2 is
abrogated [37]. Consequently, BCR ligation fails to enhance the
production of IP3 and mobilization of calcium (however, this defect
is less robust when higher levels of the mutant kinase are expressed
[155]). Defective signaling also is observed in RBL-2H3 mast cells
expressing the Syk double mutant, which cannot support the FcɛRI-
induced phosphorylation of cellular proteins – including PLC-γ2 – or
histamine release [150]. Thus, there is an intriguing lack of correlation
between the effects of activation loop phosphorylation in vitro and in
intact cells. One interesting suggestion is that the phosphorylation of
Y519 and Y520 generates a binding site for one or more intracellular
proteins such that the effects of this phosphorylation on these
interactions would be observed only in cells and not in puriﬁed
preparations of the kinase [149,150,154].
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Three adjacent tyrosines (Y623, 624 and 625 in murine Syk; Y629,
Y630 and Y631 in the human enzyme) are located near the C-terminus
of the protein. Two of these, Y624 and Y625, are phosphorylated,
albeit at a relatively low initial rate, during an autophosphorylation
reaction in vitro [15,16]. We did not detect these in our initial analysis
of phosphorylation sites modiﬁed in cells following BCR engagement
[16]. However, the phosphorylation of Syk on Y624 does occur in a
model of BCR signaling reconstituted in S2 insect cells as detected by a
phospho-speciﬁc antibody [71]. Furthermore, an analysis of the
phosphoproteome of mast cells identiﬁed a doubly phosphorylated
peptide derived from Syk that was modiﬁed on both Y624 and 625
[83]. The level of this phosphopeptide increased about two-fold
following activation of cells through the high afﬁnity IgE-receptor.
A pair of tyrosines (Y597 and 598) is located in an analogous
position near the C-terminus of Zap-70. These lie in an α-helix within
the large C-terminal lobe of the catalytic domain and play an
important role in the formation of the kinase domain/linker A
interaction that stabilizes the autoinhibited form of the kinase. These
two tyrosines form a cleft that accommodates the side chain of a
proline residue from linker A [67]. Disruption of this interaction occurs
if both residues are replaced by phenylalanines resulting in the
activation of the kinase [67,71,156]. The replacement of the three C-
terminal tyrosines of Syk also results in a gain-of-function mutant
suggesting a similar role for these residues [156]. The efﬁcient
phosphorylation of these tyrosines likely would require prior
disassembly of the linker-kinase sandwich either through the
autophosphorylation of linker B tyrosines or the binding of the
tandem SH2 domains to a phosphorylated ITAM. Likewise, the
phosphorylation of the C-terminal tyrosines would be expected to
stabilize the more active, open conformation of the kinase by
disrupting the interaction of linker A with the catalytic domain.
The sequence surrounding pY624, pYYDV, matches that of a ligand
for the SH2 domains of adaptor proteins of the SLP-family [157]. In B
cells, BLNK/SLP-65 is a major substrate of Syk whose phosphorylation
generates docking sites for a variety of effectors of BCR signaling
including PLC-γ2 and Bruton's tyrosine kinase (Btk) [157–163]. The
formation of this protein complex or “signalsome” alters the
subcellular localization of and enhances the phosphorylation and
activation of PLC-γ2 to generate IP3 and diacylglycerol leading to the
activation of protein kinase C and the mobilization of calcium. BLNK/
SLP-65 is associated with the plasma membrane in an interaction
requiring its N-terminal leucine zipper motif [164] and is recruited to
the BCR via its SH2 domain binding to the phosphorylated, non-ITAM
tyrosine Y204 of Ig-α [165,166]. This interaction is important for the
initial phase of calcium mobilization that follows clustering of BCR
complexes [71]. The activation of Syk and its subsequent phosphoryla-
tion on Y624 generates another docking site for the SH2 domain of
BLNK/SLP-65 [71]. The resulting physical interaction between Syk and
its substratemaintains the kinase in an active conformation and results
in the retention of active Syk at the plasma membrane where it can
persist even following BCR internalization [71,167]. The resulting
complex provides for the signals required for sustained calcium inﬂux.
Interestingly, the amino acids surrounding the analogous C-terminal
tyrosines of Zap-70 are not consensus sequences for binding BLNK/
SLP-65. Consequently, the TCR can signal throughectopically expressed
BLNK/SLP-65 only if Syk is co-expressed [167]. In normal T cells that
lack BLNK/SLP-65, signaling through the TCR via Zap-70 is transduced
instead by a combination of SLP76 (SH2-domain-containing leukocyte
protein of 76 kDa) and LAT (linker for activation of T cells) [168].
4. Dephosphorylation of Syk
The phosphorylation of Syk following receptor clustering occurs
rapidly due to its activation, its association with the receptor andLyn and the transient inhibition of protein-tyrosine phosphatases
resulting from BCR-stimulated increases in H2O2 [169–171]. Once
the activity of Syk is terminated, both the kinase and its substrates
are rapidly dephosphorylated and the activation of downstream
signaling pathways ends [70]. Thus, the continued activity of Syk is
necessary to maintain the kinase in an active state. The full identity
of the repertoire of protein-tyrosine phosphatases that regulate the
state of phosphorylation of Syk is most likely not completely known,
but several enzymes that alter the state of phosphorylation of the
kinase have been identiﬁed. SH2 domain-containing protein-
tyrosine phosphatase-1 (SHP-1) is recruited to immunoreceptor
tyrosine-based inhibitor motifs (ITIMs; which have a consensus
sequence I/L/V-X-pY-X-X-L/V) on inhibitory receptors such as CD22
or PIR-B following their phosphorylation by Lyn [172–177]. This
accounts, in part, for the inhibitory effects of Lyn's expression on B
cell signaling as the receptor-associated SHP-1 becomes activated
and attenuates BCR signaling by dephosphorylating multiple
components the BCR-signaling network including Syk. In fact, a
direct interaction between SHP-1 and Syk has been reported
[178,179]. Consequently, the expression of a dominant-negative
mutant of SHP-1 leads to the hyperphosphorylation of Syk [178].
Syk also is a direct substrate of protein-tyrosine phosphatase
receptor-type O truncated (PTPROt), a phosphatase whose expres-
sion is regulated during B cell development [180]. An inactive,
substrate-trapping mutant of PTPROt binds phosphorylated Syk
from lysates of pervanadate-treated cells. Interestingly, the over-
expression of PTPROt inhibits the BCR-stimulated phosphorylation
of Syk and attenuates signaling initiated through BCR engagement
as well as the tonic BCR signaling that is required for lymphoma cell
proliferation. The proline-, glutamic acid-, serine- and threonine-
enriched protein-tyrosine phosphatase, PEP, also has been impli-
cated as a negative regulator of Syk-family kinases [181]. PEP
associates with the SH3 domain of Csk (C-terminal Src kinase), a
negative regulator of Src-family kinases and of T and B cell signaling.
The enhanced expression of PEP in T cells suppresses signaling from
the TCR and reduces the phosphorylation of Zap-70. A substrate-
trapping mutant of PEP binds directly to tyrosine-phosphorylated
Zap-70. Syk also has been reported to bind and serve as a substrate
for T-cell ubiquitin ligand-2/suppressor of T-cell receptor signaling,
TULA-2/STS-2, which is an unconventional phosphatase with a
catalytic domain related to the active site of phosphoglyceromutase
[182]. The state of tyrosine-phosphorylation of Syk is reduced in
cells overexpressing TULA-2, but is enhanced in cells overexpressing
TULA-1, an inactive and putative dominant-negative inhibitor of
TULA-2. Finally, Zap-70 also serves as a substrate for the low
molecular weight phosphotyrosine phosphatase LMPTP, in an
interaction that actually stimulates the kinase through the selective
dephosphorylation of the inhibitory pY292 [183]. Thus, it appears
likely that Syk is subject to the regulatory inﬂuences of multiple
phosphatases that can catalyze its dephosphorylation, which may
account for the very rapid loss of phosphotyrosine from the kinase
that occurs following its inhibition [70].
5. Substrate speciﬁcity
Once activated, Syk catalyzes the phosphorylation of multiple
protein substrates that are important for transducing the antigen
receptor interaction into the appropriate physiological response [184].
The consequences of a protein's phosphorylation by Syk vary
depending on the nature of the substrate and the site that is modiﬁed.
For a subset of Syk's substrates, the addition of a phosphate group
induces conformational changes that lead to alterations in the
intrinsic activity of the phosphorylated protein. The phosphorylation
on tyrosine of PLC-γ2, Btk, hematopoietic progenitor kinase-1 (HPK1)
and the Vav1 guanine nucleotide-exchange factor leads to their
activation [185–192]. For many substrates, phosphorylation on
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ing docking sites that are recognized by proteins that have SH2
domains or other phosphotyrosine-binding motifs. In fact, it has been
observed that Syk demonstrates a preference for the phosphorylation
of tyrosines within motifs that can then be recognized by group I SH2
domains [193]. Thus, the phosphorylation of many substrates for Syk
including BLNK/SLP-65, LAB/NTAL/LAT2, 3BP2, BCAP, BANK and GCET
generates scaffolds for the assembly of larger signaling complexes
[114,194–203]. For example, the phosphorylation of BLNK/SLP-65, a
major Syk substrate in B cells, creates docking sites that bind Btk and
PLC-γ to generate a protein complex that regulates themobilization of
calcium [157–163].
It is less well recognized that phosphorylation also can inhibit
rather than promote protein–protein associations. For example, in red
blood cells the acidic cytoplasmic tail of the anion transport channel
protein, band 3, binds to and inhibits the activities of several of the
glycolytic enzymes including aldolase and glyceraldehyde-3-phos-
phate dehydrogenase (G3PDH). The phosphorylation of Y8 on band 3
by Syk blocks these interactions and relieves the inhibition [204].
Structural analyses indicate that the region surrounding Y8 forms a
loopwith the tyrosine located in the center where it interacts with the
hydrophobic side chains of neighboring amino acids [205,206]. The
side chains of the surrounding acidic amino acids are oriented
outward and mediate electrostatic interactions with basic residuesTable 2
Syk substrates and sites of phosphorylation.
Substrate Site(s) Ref.
3BP2 YPMDNEDYEHEDEDD [201]
HEDEDDSYLEPDSPG
EEDSDEDYEKVPLPN
Band 3 MEELQDDYEDMMEEN [208,210]
ENLEQEEYEDPDIPE
AKPDSSFYKGLDLNG
EEEGRDEYDEVAMPV
BLNK/SLP65 SDDFDSDYENPDEHS [158,163]
EHSDSEMYVMPAEEN
EENADDSYEPPPVEQ
LLEDEADYVVPVEDN
VEDNDENYIHPTESS
Btk RYVLDDEYTSSVGSK [188]
Cbl EGEEDTEYMTPSSRP [211]
SENEDDGYDVPKPPV
CD79a EYEDENLYEGLNLDD [53]
NLDDCSMYEDISRGL
GCET2 GNSAEEYYENVPCKA [203]
LGGTETEYSLLHMPS
FcγRIIA LEETNNDYETADGGY [212]
TDDDKNIYLTLPPND
GS PEEDGERYDEDEEAA [213]
HPK1 LSDSDDDYDDVDIPA [189]
HS1 EPEPENDYEDVEEMD [214–216]
EDEPEGDYEEVLEPE
LAB EDDDANSYENVLICK [217]
EDEESEDYQNSASIH
EEDGEPDYVNGEVAA
PKCA SDFEGFSYVNPQFVH [218]
PLC-γ1 IGTAEPDYGALYEGR [173]
SLP76 SSFEEDDYESPNDDQ [219]
DGEDDGDYESPNEEE
SYNA VDPDNEAYEMPSEEG [220]
EMPSEEGYQDYEPEA
SEEGYQDYEPEA
TUBA MAALEKDYEEVGVDS [72]
Vav1 EAEGDEIYEDLMRSE [193]
Consensus EXXDEEDYEXPXEPX
Abbreviations: 3BP2, SH3-domain binding protein 2; Band 3, erythrocyte anion
transport channel; BLNK/SLP-65, B cell linker protein/SH2 domain-containing
leukocyte protein of 65 kDa; Btk, B Bruton's tyrosine kinase; Cbl, Casitas B-lineage
lymphoma protein; GCET2, germinal center expressed transcript 2; GS, glycogen
synthase; HPK1, hematopoietic progenitor kinase-1; HS1, hematopoietic lineage cell-
speciﬁc protein-1; LAB, linker for activation of B cells; PKCA, protein kinase C-α; PLC-
γ1; phospholipase C-γ1; SYNA, α-synuclein; TUBA, α-tubulin.in the active sites of both aldolase and G3PDH to inhibit their
activities. The phosphorylation of this tyrosine by Syk destabilizes the
loop through electrostatic repulsion and abrogates the band 3/
enzyme interactions. This type of loop structure has been termed a
phosphorylation sensitive interaction (PSI) loop. It is reasonable to
speculate that this mechanism will be important to the regulation of
additional protein–protein interactions. It is interesting to note, for
example, that the acidic C-terminus of α-tubulin also binds glycolytic
enzymes and is an excellent substrate for Syk [72,207].
Many of the substrates of Syk can be recruited directly to the kinase
or to kinase-adaptor or kinase-receptor complexes through interac-
tions mediated by structural motifs such as SH2 or SH3 domains.
These interactions that occur outside of Syk's active site serve to bring
the kinase and substrates together in close proximity. However, the
speciﬁc tyrosine that is phosphorylated is also determined by the
nature of the amino acids in its immediate vicinity. Syk exhibits a
marked preference for the phosphorylation of tyrosines surrounded
bymultiple acidic amino acids. This was ﬁrst demonstrated for band 3,
which Syk readily phosphorylates both in vitro and in intact
erythrocytes [11,204,208]. The highly acidic, cytoplasmic fragment of
band 3 or substrates based on its sequence are frequently used in
kinase assays for the detection and quantiﬁcation of Syk's catalytic
activity. Studies on the speciﬁcity of Syk using as substrates members
of a phage display library identify a preferred recognition sequence of
E/DE/DEE/DYEE, consistent with a preference for tyrosines
embedded within highly acidic sequences [209]. For several of Syk's
protein substrates, phosphorylation sites with these characteristics
also have been identiﬁed (Table 2). A comparison of these sites yields
a consensus sequence consistent with the results of the peptide library
screen. Thus, the same substrate speciﬁcity for Syk extends to both
peptides and proteins.
6. Conclusions
Aggregation of the B cell antigen receptor leads to its association
with Lyn and the subsequent phosphorylation of the ﬁrst ITAM
tyrosines of Ig-α and Ig-β. The recruitment of Syk, likely via its C-
terminal SH2 domain, to the phosphorylated ITAM allows Syk to
catalyze the phosphorylation of the more C-terminal tyrosines of each
ITAM allowing the recruitment of additional Syk molecules to the
clustered BCR complexes. This binding of Syk to the dually
phosphorylated ITAM and its phosphorylation by Lyn and/or its
autophosphorylation on Y342 and Y346 in linker B (and perhaps of
Y519 and 520 in the activation loop) fully activates the kinase.
Depending on the sites that are phosphorylated and the stoichiometry
of their phosphorylation, the phosphotyrosines within linker B serve
as sites for protein–protein interactions that help to amplify weak
signals. The phosphorylation of Y317 by Lyn, in turn, dampens
signaling in a Cbl-dependent manner, but is important for signaling
to PI3K through other receptors involved in such processes as
phagocytosis andmotility. Once activated, Syk phosphorylates protein
substrates on tyrosines located within highly acidic regions. These
include enzymes whose activity is enhanced as well as adaptor
proteins whose phosphorylation promotes the assembly of signaling
complexes through the recruitment of proteins containing phospho-
tyrosine-interacting domains. The binding of one of these adaptor
proteins, BLNK/SLP-65, to the phosphorylated C-terminal tyrosines of
Syk anchors the active kinase to the plasma membrane to promote
more extended signaling. Activated Syk can also dissociate from the
receptor and appear in an active form in locations within the cell other
than the plasma membrane including the nucleus. The phosphoryla-
tion of Y130 provides onemechanism for this dissociation. Signaling is
terminated through the down-regulation of membrane-bound recep-
tors and through the dephosphorylation of Syk and its substrates by
one or more of several candidate phosphatases. Thus, multiple factors
act in concert to inﬂuence the activity of Syk in order to regulate the
1123R.L. Geahlen / Biochimica et Biophysica Acta 1793 (2009) 1115–1127quality and quantity of the signal that is sent from the BCR, which
ultimately determines the physiological outcome of receptor
engagement.
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